Advertisement
Research ArticleInfectious diseaseMicrobiology Open Access | 10.1172/JCI166710
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by Grassmann, A. in: JCI | PubMed | Google Scholar |
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by Tokarz, R. in: JCI | PubMed | Google Scholar
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by Golino, C. in: JCI | PubMed | Google Scholar
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by McLain, M. in: JCI | PubMed | Google Scholar
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by Groshong, A. in: JCI | PubMed | Google Scholar
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by Radolf, J. in: JCI | PubMed | Google Scholar
1Department of Medicine, UConn Health, Farmington, Connecticut, USA.
2Center for Infection and Immunity and
3Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
4Department of Pediatrics,
5Department of Molecular Biology and Biophysics,
6Department of Genetics and Genome Sciences, and
7Department of Immunology, UConn Health, Farmington, Connecticut, USA.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Find articles by Caimano, M. in: JCI | PubMed | Google Scholar |
Published January 17, 2023 - More info
The RNA polymerase alternative σ factor RpoS in Borrelia burgdorferi (Bb), the Lyme disease pathogen, is responsible for programmatic-positive and -negative gene regulation essential for the spirochete’s dual-host enzootic cycle. RpoS is expressed during tick-to-mammal transmission and throughout mammalian infection. Although the mammalian-phase RpoS regulon is well described, its counterpart during the transmission blood meal is unknown. Here, we used Bb-specific transcript enrichment by tick-borne disease capture sequencing (TBDCapSeq) to compare the transcriptomes of WT and ΔrpoS Bb in engorged nymphs and following mammalian host-adaptation within dialysis membrane chambers. TBDCapSeq revealed dramatic changes in the contours of the RpoS regulon within ticks and mammals and further confirmed that RpoS-mediated repression is specific to the mammalian-phase of Bb’s enzootic cycle. We also provide evidence that RpoS-dependent gene regulation, including repression of tick-phase genes, is required for persistence in mice. Comparative transcriptomics of engineered Bb strains revealed that the Borrelia oxidative stress response regulator (BosR), a noncanonical Fur family member, and the cyclic diguanosine monophosphate (c-di-GMP) effector PlzA reciprocally regulate the function of RNA polymerase complexed with RpoS. BosR is required for RpoS-mediated transcription activation and repression in addition to its well-defined role promoting transcription of rpoS by the RNA polymerase alternative σ factor RpoN. During transmission, ligand-bound PlzA antagonizes RpoS-mediated repression, presumably acting through BosR.
Lyme disease (LD) is a multisystem infectious disorder caused by the highly motile, invasive spirochetal pathogen Borrelia burgdorferi (Bb) (1). With an estimated 476,000 cases diagnosed and treated annually, LD is easily the most prevalent arthropod-borne infection in the United States (2). In nature, Bb cycles between an Ixodes species vector and a vertebrate reservoir host, usually a small rodent; in North America, it is primarily the white-footed mouse (3, 4). The generalist feeding behavior of Ixodes species is responsible for transmission of B. burgdorferi to humans by infected ticks (1, 5). In recent years, much has been learned about the global regulatory systems that enable LD spirochetes to transit between their arthropod vector and mammalian reservoir host (6, 7). However, while there is ample evidence for crosstalk between pathways (7), the mechanisms by which they modulate each other’s regulatory output to create the appropriate transcriptomic and proteomic profile at a given point in the enzootic cycle remain obscure.
The RNA polymerase alternative σ factor RpoN/RpoS regulatory pathway, first described in a seminal report by Norgard and colleagues (8), controls gene expression via the effector alternative σ factor RpoS. RpoN, the LD spirochete’s sole other alternative σ factor (9), transcribes rpoS in response to environmental cues provided by the blood meal (6, 7); the pathway remains on throughout tick transmission and mammalian infection but rapidly turns off during larval acquisition (10–12). Spirochetes lacking RpoS are avirulent when introduced into mice by needle inoculation (6) and remain confined to the midgut during feeding when they are artificially introduced into ticks by immersion (13). The response regulatory protein 2 (Rrp2) and Borrelia oxidative stress response regulator (BosR), a ferric uptake regulator (fur) ortholog, are essential for transcription of rpoS in vitro and in vivo, presumably forming a complex with RNA polymerase–RpoN (RNAP-RpoN) holoenzyme (7). Comparison of the transcriptomes of Bb cultivated in vitro at 37°C and following mammalian host–adapted in dialysis membrane chambers (DMCs) (14) have brought to light 2 salient differences between the in vitro and in vivo RpoS regulons (11, 15). First, not all genes transcribed by RpoS in mammals are transcribed by RpoS in vitro, and, second, RpoS represses a subset of tick-phase genes upon mammalian host-adaptation but not in vitro. These differences imply that promoter recognition by RpoS differs in vitro and within mammals. The ability of RpoS to reciprocally regulate tick- and mammalian host–phase genes throughout the enzootic cycle led to its designation as the gatekeeper (15).
A second global regulatory system in Bb involves the ubiquitous bacterial second messenger bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) and the sensory transduction histidine kinase 1/response regulatory protein 1 (Hk1/Rrp1) two-component system (TCS) (7, 16). Binding of unidentified, exogenous ligand(s) generated within the midgut of feeding ticks to the periplasmic sensor domain of Hk1 initiates a signal-transduction cascade that culminates in phosphorylation of Rrp1 and synthesis of c-di-GMP (7, 16). Spirochetes lacking either Hk1 or Rrp1 host-adapt normally within DMCs and are virulent in mice but are destroyed within feeding ticks (10, 17–19). Thus, in contrast to the RpoN/RpoS pathway, the Hk1/Rrp1 pathway is tick-specific. Production of c-di-GMP by Bb results in the upregulation of genes involved in the utilization of alternative carbon sources and genes encoding cell envelope constituents required to defend against noxious substances and environmental stressors generated by the blood meal (20–22). Importantly, many tick-phase genes upregulated by c-di-GMP are repressed by RpoS within mammals (11). Efforts to elucidate c-di-GMP signaling in Bb have centered about PlzA, the sole PilZ domain protein in most LD spirochetes, including the B31 strain (7, 16, 23). In feeding ticks, deletion of plzA or complementation of ΔplzA with a PlzA protein unable to bind c-di-GMP, phenocopies deletion of hk1 and rrp1 (19, 24, 25). Our recent studies with the DMC system revealed that ectopic constitutive synthesis of c-di-GMP by cDGC Bb, acting through ligand-bound PlzA, exerts a ‘brake’ effect on RpoS-dependent gene regulation, antagonizing RpoS-mediated repression and reducing expression of some RpoS-upregulated genes (25). We interpreted these results to indicate that ligand-bound PlzA is a principal driver of RNAP-RpoS function in ticks and that transition to the mammalian host-phase RpoS regulon requires cessation of c-di-GMP synthesis.
Deconvolution of the processes shaping the RpoS regulon requires transcriptional profiling of WT and ΔrpoS spirochetes in feeding nymphs as well as in mammals. While DMCs provide sufficient host-adapted spirochetes for genome-wide transcriptomics, conventional RNA-Seq of Bb in feeding nymphs is not feasible due to an abundance of mouse and tick RNA. We circumvented this problem using probe-based enrichment prior to RNA-Seq to compare the WT and ΔrpoS transcriptomes in engorged nymphs and DMCs. These analyses revealed that the RpoS regulon changed dramatically as spirochetes transited from tick to mammal, with RpoS-mediated repression occurring strictly within mammals. RNA-Seq analysis of the cDGC strain in DMCs revealed that ligand-bound PlzA skewed the RpoS regulon toward a ‘tick-phase’ transcriptional profile. Using a ΔrpoS strain that expressed rpoS from an IPTG-inducible promoter (ΔrpoS/irpoS), we determined that persistence in mammals involved RpoS-upregulated genes as well as RpoS-mediated repression. Inactivation of bosR in ΔrpoS/irpoS abrogated RpoS-mediated repression and diminished RpoS-upregulation in DMCs. Thus, BosR was required not only for RpoN-dependent transcription of rpoS but also for downstream RpoS-dependent facets of host-adaptation. Remarkably, ectopic expression of RpoS in a ΔbosRΔrpoS/irpoS background phenocopied the ‘brake effect’ of ligand-bound PlzA on RpoS-mediated repression in DMCs. Collectively, these results enabled us to formulate a working model whereby ligand-bound PlzA counteracted BosR during transmission to antagonize RpoS-mediated repression of tick-phase genes and diminish expression of RpoS-upregulated genes. Cessation of c-di-GMP synthesis with consequent release of PlzA-dependent antagonism following transmission reset RNAP-RpoS to its default position, which was maintained throughout mammalian infection.
Development of capture-based enrichment RNA-Seq to delineate RpoS-regulated genes in engorged nymphal ticks
Using comparative microarray and RNA-Seq, we previously defined the Bb RpoS regulon following temperature-shift in vitro and cultivation within DMCs (11, 15). Collectively, these studies demonstrated that mammalian host signals modulate promoter recognition by RNAP-RpoS and license RpoS-mediated repression of tick-phase genes. Notably, these studies identified a cohort of genes upregulated by RNAP-RpoS only in mammals. Given that RpoS is essential for transmission (13), we reasoned that the RpoS regulon includes genes upregulated exclusively during the nymphal blood meal. In a pilot RNA-Seq study using ribodepleted RNA from engorged nymphs infected with WT strain B31, only approximately 6,700 reads mapped to protein coding genes (0.034% of approximately 20 million total raw reads) (Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/JCI166710DS1), a value too low to obtain comprehensive transcriptomic data. To overcome this bottleneck, we took advantage of an enrichment strategy, designated TBDCapSeq, developed by Tokarz and colleagues (26, 27), which uses hybridization probes to ‘capture’ pathogen-specific amplicons prior to sequencing (Figure 1). Using TBDCapSeq, we compared the transcriptomes of WT and ΔrpoS Bb in fed nymphs and DMCs. Summaries of the raw and mapped data are presented in Supplemental Table 1.
Workflow for TBDCapSeq. Total RNA extracted from fed nymphs infected with either WT (green) or ΔrpoS (magenta) Bb was converted to cDNA and used as input for second-strand synthesis. Libraries were prepared using dual-indexes (blue and red). Following precapture amplification, libraries were hybridized to Bb-specific biotinylated probes. Bb-specific amplicon–probe duplexes were captured using magnetic streptavidin beads (lilac), amplified using Illumina universal primers, and sequenced on a NextSeq2000. Raw reads were mapped using EDGE-pro and analyzed for differential gene expression using DESeq2. TBDCapSeq for DMC-cultivated samples was performed using the same pipeline.
Overview of TBDCapSeq analyses
Approximately 11.3 and 15.6 million raw reads were obtained from fed nymphs infected with WT and ΔrpoS strains, respectively. Of these, approximately 30% were Bb-specific, representing an approximately 1,000-fold enrichment over conventional RNA-Seq. After post-run processing, approximately 1.6 and 1.9 million reads for protein coding genes in WT and ΔrpoS, respectively, remained. Of the 1,227 protein coding genes used for mapping, roughly 1,000 were detected at more than 10 transcripts per kilobase million (TPMs) in all 3 biological replicates (Supplemental Table 2). We obtained even more robust data for DMC-cultivated spirochetes. Of the approximately 44 million total reads obtained for WT and approximately 35 million total reads obtained for ΔrpoS DMC samples, roughly 21 and 17 million were Bb-specific, with 79 and 73% mapping to protein coding genes, respectively. Approximately 1,200 genes were detected at at least 10 TPMs in all 4 biological replicates (Supplemental Table 2). Prior microarray analyses demonstrated extensive transcriptomic remodeling as spirochetes transit between ticks and mammals (28). Along these lines, hierarchical clustering and Principal Component Analysis (PCA) plots (Figure 2) showed wide separation of WT transcriptomes in fed nymphs and mammals. The distance between WT and ΔrpoS suggests that RpoS is a major contributor to this transcriptional divergence. Indeed, DESeq2 identified 213 genes differentially regulated by RpoS in fed nymphs and/or DMCs. Of the 170 RpoS-regulated genes identified in DMCs, all but 3 (bb0228, bb0454, and bbb29/malX-2) were restored to near-WT levels by trans-complementation with rpoS expressed under its native promoter (Supplemental Table 3). To ascertain the extent of bias introduced by enrichment, we compared the RpoS DMC regulons obtained by TBDCapSeq and conventional RNA-Seq (11). Of the 98 RpoS-regulated genes identified in DMCs by conventional RNA-Seq, 89 — 55 upregulated and 34 repressed — were similarly regulated by TBDCapSeq (Supplemental Table 3). The high degree of overlap between these independent data sets minimized concerns that enrichment faithfully represents the spirochete transcriptome in a given milieu.
The contour of the Bb transcriptome varies substantially across the feeding nymphal tick and mammalian host phases of the enzootic cycle. Hierarchical clustering (A) and PCA plots (B) for WT and ΔrpoS Bb in fed nymphs (3 biological replicates per strain) and following cultivation in DMCs (4 biological replicates per strain) were generated using R Studio.
The RpoS regulon changes dramatically when LD spirochetes transits from ticks to mammals
Genome-wide comparisons of WT and ΔrpoS Bb in fed nymphs and DMCs revealed that the RpoS regulon varies substantially across the enzootic cycle (7, 13). Of note, all key components of the RpoN/RpoS pathway (bb0647/bosR, bb0763/rrp2, bb0450/rpoN and bb0771/rpoS) were expressed at comparable levels in fed nymphs and DMCs (Supplemental Table 4), arguing against fluctuations in RpoS protein levels being responsible for these differences. 4 categories of differentially expressed genes were identified: (a) core genes upregulated by RpoS in both nymphs and DMCs; (b) genes upregulated by RpoS only in nymphs; (c) genes upregulated by RpoS only in DMCs; and (d) genes repressed by RpoS in mammals. Notably, no genes were repressed by RpoS during tick feeding.
Genes upregulated by RpoS in fed nymphs and DMCs. In both fed nymphs and DMCs, 52 genes were upregulated by RpoS (hereafter designated core genes) (Supplemental Table 5). Eleven, including the RpoS-upregulated prototypes bbb19/ospC and bba24/dbpA, are known to be transcribed exclusively by RpoS (i.e., absolutely RpoS-dependent) in vitro and/or in DMCs (11, 13, 15, 29). Based on a comparison of TPM values for WT and ΔrpoS samples (Supplemental Table 2), 27 additional core genes also are considered absolutely RpoS-dependent. Twenty-two of the 38 absolutely RpoS-dependent core genes, most notably ospC, dbpA and bbi42, were transcribed at comparable levels in fed nymphs and DMCs. Thirteen, including 3 Pfam54_60 paralogs (bba65, bba66 and bba73), the OspF paralog bbo39 (erpL), and 2 Mlps (bbp28/mlpA and bbm28/mlpF), were transcribed at higher levels in fed nymphs, while 18 were higher in DMCs. The DMC-enhanced group included vlsE1, the expression site for the Vls system for antigenic variation (30), bba34/oppA5, encoding an oligopeptide substrate binding protein (11, 31), and bbk32, encoding a vascular endothelial adhesin and inhibitor of the classical complement pathway (32–34). Seven core genes, including 5 related to chemotaxis (bb0680/mcp4, bb0681/mcp5, bb0671/cheX, bb0567/cheA-1, and bb0565/cheW-2), were transcribed at appreciable levels by Δ rpoS Bb, indicating dual transcription by RpoS and RpoD. An additional 6 core genes (bb0400, bb0798, bbi42, bbj27, bbk53, and bbq03), all encoding hypothetical proteins, were dually transcribed by RpoS and RpoD only in DMCs.
Genes upregulated by RpoS only during tick transmission. (Supplemental Table 6). Forty-four genes were designated tick-only genes because they were upregulated by RpoS only in feeding nymphs and not in DMCs. Of the 44, 40 were transcribed exclusively by RpoS in fed nymphs, while the remaining 4 (bb0418/dipA, bb0637/nhaC1, bb0729/gltP, and bbh09) were dually transcribed by RpoS and RpoD with a significant contribution to their expression from the former σ factor. In contrast, in DMCs, all 44 were either transcribed exclusively by RpoD or dually transcribed, but the contribution of RpoS to their expression was not statistically significant. Thus, the σ factor selectivity for genes in this group differs between ticks and mammals, with significant upregulation by RpoS occurring only in fed nymphs (≥ 3-fold difference with q ≤ 0.05). Nine tick-only genes, including the Pfam54_60 paralogs bba64 and bbe31, are required for transmission (35–38).
Genes upregulated by RpoS only within mammals. (Supplemental Table 7). Forty genes were upregulated by RpoS only within DMCs. Unlike the tick-only genes, which were transcribed to varying extents in ticks and mammals, the vast majority of DMC-only RpoS-upregulated genes were expressed exclusively in mammals (Supplemental Table 2). Two-thirds, 67%, of the DMC-only genes appeared to be absolutely RpoS-dependent, including 17 encoded on lp28-2; the contribution of this linear plasmid to virulence has not been established (11, 39). The remaining 13 DMC-only genes, including 5 related to motility and chemotaxis (bb0273/fliR, bb0578/mcp-1, bb0669/cheA-2, and bb0670/cheW-3), were dually transcribed by RpoS and RpoD in mammals.
Genes repressed by RpoS within mammals. (Supplemental Table 8). Seventy-seven RpoS-regulated genes were expressed at significantly lower levels in WT versus ΔrpoS in DMCs and, hence, are repressed by RpoS “(≥ 3-fold difference with q ≤ 0.05). RpoS-repressed genes fell into 2 groups. The first consisted of genes that were expressed at comparable levels by WT and ΔrpoS Bb in fed nymphs but were strongly repressed by RpoS in DMCs. Twenty of these tick-phase genes, including bba15/ospA, bba16/ospB, bba62/lp6.6, bba68/BbCRASP1, and the glp operon (bb0240-0243), were shown previously to be repressed by RpoS in mammals (11, 15, 25). TBDCapSeq also identified an additional 10 RpoS-repressed genes in this group, including bb0330/oppA3, encoding an oligopeptide substrate binding protein (31), and bba69, encoding a Pfam54_60 lipoprotein (35). The remaining 47 RpoS-repressed genes were transcribed by WT Bb at comparably low levels in feeding nymphs and DMCs, but showed increased expression in the absence of RpoS in DMCs. This second category of RpoS-repressed genes included 3 closely related Pfam54_60 paralogs (bbi36, bbi38, and bbi39) (35) and bbd18, encoding a known regulator of RpoS protein levels (40, 41). Given its importance to the RpoS pathway, we confirmed the expression profile for bbd18 by qRT-PCR. bbd18 was transcribed at virtually identical low levels in fed nymphs and DMCs but was upregulated 10-fold in DMC-cultivated ΔrpoS Bb (Supplemental Figure 1). Presumably, RpoS-mediated repression of bbd18 in mammals ensured that levels of this regulatory protein remain low in mammals, when RpoS is essential.
Genes differentially regulated in feeding nymphs and/or mammals independent of RpoS
A dividend of TBDCapSeq is that it enables assessment of the RpoS-independent as well as the RpoS-dependent components of the Bb transcriptome in ticks and mammals (Supplemental Table 9). Examination of hierarchical clustering and PCA plots for ΔrpoS in fed nymphs and DMCs (Figure 2) suggested that RpoS-independent, differentially expressed genes comprise a substantial component of the WT transcriptomes in these 2 milieus. After excluding RpoS-regulated genes, 250 genes differed by more than 3-fold (q ≤ 0.05) between feeding nymphs and DMCs (Supplemental Table 9). Seventy-five genes were expressed at higher levels in fed nymphs, while 175 were higher in DMCs. Most of the RpoS-independent genes upregulated in feeding nymphs encode proteins with housekeeping functions — i.e., DNA replication, cell division, and protein translation and turnover — or functions related to nutrient acquisition and intermediary metabolism. Utilization of alternate carbon sources is critical to spirochete fitness in ticks (42, 43). Five genes (bb0166/malQ, bb0367, bb0557/ptsH-2, bb0559/crr, and bb0629/fruA-2) encode components of the phosphoenolpyruvate-dependent sugar phosphotransferase system — the spirochete’s central pathway for carbohydrate transport (42, 43) — and could be involved in uptake of alternative carbon sources. Eight are related to cell wall biosynthesis, including the chitobiose transporter bbb04-06/chbCAB, as well as bb0151/nagA, bb0201/murE, and bb0841/arcA. Increased expression of chb is particularly noteworthy given that chitobiose can be used for energy generation as well as cell wall biosynthesis (20, 44). Finally, 3 encode putative regulatory proteins — BB0355, a CarD-like transcriptional regulator required for transmission (45); BB0785/SpoVG, a tick-phase DNA/RNA-binding protein of undetermined function (46, 47); and BB0047/BpuR, a DNA/RNA-binding protein — were upregulated in feeding ticks (48) (Supplemental Table 4). Of the 75 RpoS-independent genes, 6 (bb0166/malQ, spoVG, bbb04-06/chbCAB, and bbb07) expressed at higher levels in fed nymphs are upregulated by c-di-GMP in vitro (10).
While a large majority (78%) of RpoS-independent genes upregulated in DMCs encode hypothetical proteins, 14 encode gene products related to DNA replication (bb0455, bb0552/ligA, and bb0632/recD), influx/efflux of small molecules (bb0642/potA and bb0641/potB), biosynthesis of metabolic cofactors (bb0782/nadD and bb0589/pta), purine salvage (bb0384/bmpC, bb0467, bb0524, and bbb23), and maintenance of the cell envelope (bb0304/murF, bb0586/femA, and bb0721/pgsA) (49–54). Also noteworthy, bb0733/plzA, which has a virulence-related function in mice unrelated to binding of c-di-GMP (23–25), was upregulated in DMCs compared with fed nymphs. With the exception of rrp1, which was slightly higher in mammals, all other known or putative regulatory factors (7) were expressed at comparable levels in both milieus (Supplemental Table 4).
Ligand-bound PlzA impairs RpoS-mediated repression and diminishes transcription of some RpoS-upregulated genes
Using a strain, cDGC, that constitutively synthesizes c-di-GMP in mammals, we previously demonstrated that ligand-bound PlzA acts as a ‘brake’ on RpoS-dependent gene regulation, antagonizing RpoS-mediated repression and diminishing expression of RpoS-upregulated genes (25). These data led us to propose that ligand-bound PlzA is a principal determinant of the RpoS regulon during transmission and, moreover, that transition to the mammalian host-phase RpoS regulon requires cessation of c-di-GMP synthesis. To garner support for this notion on a genome-wide scale, we performed TBDCapSeq on isogenic WT, cDGC, and cDGCΔplzA strains cultivated in DMCs (Supplemental Tables 5–8). As noted previously (25), transcripts for rpoS were unaffected by either increased c-di-GMP or loss of PlzA (Supplemental Table 4). In contrast, ligand-bound PlzA had a striking effect on the RpoS regulon. Of the 77 genes repressed by RpoS in DMCs, 57, including 26 of the 30 tick-phase genes noted above, were expressed at significantly higher levels in cDGC compared with WT (≥ 3-fold difference with q ≤ 0.05). In every case, deletion of plzA restored RpoS-mediated repression in the cDGCΔplzA strain. The modulatory effect of ligand-bound PlzA in mammals also extended to 17 RpoS-upregulated genes. Expression of 10 RpoS core genes, including ospC, dbpA, bbk32, and vlsE1, and 7 DMC-only genes decreased significantly in the cDGC strain compared with WT; all but 2 (bb0580 and bb0578/mcp-1) were absolutely RpoS-dependent (≥ 3-fold difference with q ≤ 0.05). In all but 1 case, deletion of PlzA in the cDGC strain restored RpoS-upregulation to WT levels; vlsE1, the sole outlier, was transcribed at lower levels in the cDGC strain in a PlzA-independent manner (Supplemental Table 5). Expression of vlsE1 also requires the trans-acting factor YebC (55). The negative effect of c-di-GMP on RpoS-upregulation of vlsE1 raises the possibility that YebC is c-di-GMP-regulated through some unknown mechanism. Of note, 4 tick-only RpoS-upregulated genes (bbh32, bbk01, erpA, and erpB) were transcribed at higher levels by cDGC in a PlzA-dependent manner. A question that arose from the above data was whether ligand-bound PlzA acts predominantly on genes within the RpoS regulon. As illustrated by the PCA plot and hierarchical clustering (Figure 3), synthesis of c-di-GMP in mammals appears to shift the transcriptome of cDGC toward that of ΔrpoS, while cDGCΔplzA clustered closely with WT (Figure 3A). Collectively, these data suggested that the modulatory effect of c-di-GMP on RNAP-RpoS was largely PlzA-dependent and that the influence of ligand-bound PlzA outside of the RpoS regulon was negligible.
Interplay between RpoS, BosR, and ligand-bound PlzA regulates differential gene expression in feeding nymphal ticks and mammals. PCA (A) and hierarchical clustering (B) for (i) DMC-cultivated isogenic WT (WT-BbP1781), ΔrpoS, and ΔbosRΔrpoS/irpoS with and without IPTG; (ii) DMC-cultivated isogenic WT (WT-BbP1473), cDGC, and cDGCΔplzA; and (iii) isogenic WT (WT-BbP1781) and ΔrpoS within fed nymphs.
Persistence of Bb infection in mice requires RpoS and involves RpoS-mediated repression of tick-phase genes
Using a ΔrpoS strain complemented in trans (11), we previously demonstrated that loss of the complementing plasmid placed spirochetes at a survival disadvantage for up to 20 weeks following needle inoculation, supporting a requirement for RpoS during persistent infection. These studies also suggested that RpoS-mediated repression is maintained throughout infection. To confirm the requirement for RpoS-upregulated genes and RpoS-mediated repression for persistence, we developed a ΔrpoS strain (ΔrpoS/irpoS) harboring an IPTG-inducible copy of the rpoS gene inserted into the highly stable endogenous cp26 plasmid (25). When cultivated in vitro, ΔrpoS/irpoS expressed RpoS and prototypical RpoS-upregulated gene products in an IPTG concentration–dependent manner (Supplemental Figure 2A). As previously reported (56), over-expression of rpoS (i.e., more than 50 μM IPTG) was toxic (Supplemental Figure 2B). To determine whether physiological levels of RpoS could be induced in ΔrpoS/irpoS within animals, we implanted DMCs containing ΔrpoS/irpoS into rats receiving IPTG in their drinking water. Oral administration of IPTG yielded levels of RpoS and RpoS-upregulated proteins and repression of OspA and GlpD at levels comparable to those of DMC-cultivated WT Bb (Figure 4A). By immunoblot, we also confirmed the RpoS-dependence of vlsE1 revealed by RNA-Seq (Figure 4A).
Ligand-bound PlzA and BosR modulate the RpoS regulon in a reciprocal manner within mammals. (A) Lysates from DMC-cultivated WT, ΔrpoS/irpoS, ΔbosRΔrpoS/irpoS, cDGC, and cDGCΔplzA were separated by SDS-PAGE and stained with silver or immunoblotted with antisera against FlaB, RpoS, OspA, GlpD, OspC, DbpA, BBK32, and VlsE. (B) Lysates from DMC-cultivated WT, ΔbosR/irpoS, and bosRcomp/irpoS were separated by SDS-PAGE and stained with silver. Molecular weight markers (kDa) are shown at the left of each gel. “+” and “–” indicate the presence or absence of IPTG, RpoS, BosR, and PlzA, and/or c-di-GMP synthesis by the constitutively active diguanylate cyclase in cDGC strains. A and B show representative images from 3 biological replicates per strain. Uncropped immunoblots for Figure 4A are provided in Supplemental Figure 5.
Having established that ΔrpoS/irpoS Bb host-adapts normally in rats given IPTG, we used this strain to assess the contribution of RpoS to persistence in mice. First, we confirmed the infectivity of ΔrpoS/irpoS by inoculating C3H/HeJ mice. As shown in Table 1, nearly all tissues from mice infected with either WT — which received untreated water — or ΔrpoS/irpoS — which received IPTG-treated water — were culture-positive 2-weeks after inoculation, while untreated mice infected with ΔrpoS/irpoS were culture-negative. Tilly and colleagues (57, 58) previously established that OspC is dispensable for infectivity by approximately 21 days after inoculation. To avoid an OspC-related phenotype in our persistence experiments, C3H/HeJ mice infected with ΔrpoS/irpoS were maintained on IPTG-treated water for at least 4 weeks after inoculation (Figure 5A). At the 4-week time point, IPTG was removed from half of the ΔrpoS/irpoS-infected mice, while the other half was maintained on IPTG-treated water. At 6 and 8 weeks after inoculation, WT- and ΔrpoS/irpoS-infected mice maintained on IPTG were culture positive from most tissues (Table 2). However, 2 weeks after stopping IPTG-treatment (6 weeks after inoculation), only 4 of 30 tissues from ΔrpoS/irpoS-infected mice were culture positive, with a single positive site per animal. All tissues from ΔrpoS/irpoS-infected mice were culture negative 4 weeks after discontinuation of IPTG treatment. Antibodies against OspC were detected in sera from all mice 8 weeks after inoculation (Figure 5B). Strikingly, ΔrpoS/irpoS-infected mice mounted strong anti-OspA responses after discontinuation of IPTG-treatment, whereas OspA antibodies were not detected in ΔrpoS/irpoS-infected mice continuing to receive IPTG (Figure 5B).
RpoS is required for persistence in mice. (A) Experimental design to assess the contribution of RpoS to persistence in C3H/HeJ and SCID mice (5 mice per condition, per time point). Mice infected with ΔrpoS/irpoS received IPTG-treated water (blue) 1 week before inoculation. Serology was performed 4 weeks after inoculation to confirm infection (Supplemental Figure 3). At 4 weeks, IPTG was withdrawn from half of the ΔrpoS/irpoS-infected mice, while the other half received IPTG for the remainder of the experiment. WT-infected mice received untreated water (white) throughout the experiment. At 6 and 8 weeks after inoculation (p.i.), mice were euthanized for collection of blood for serology and tissues for culture (Table 2). (B) Loss of RpoS was associated with production of antibodies against OspA. Sera from individual C3H/HeJ mice collected at 6 and 8 weeks after inoculation was assayed by immunoblot using 100 ng of recombinant OspA. Sera collected 8 weeks after infection was also assayed against 100 ng of recombinant OspC. Uncropped immunoblots for Figure 5B are provided in Supplemental Figure 6.
To investigate whether antibodies were responsible for clearance of ΔrpoS/irpoS following withdrawal of IPTG, we repeated the above experiment using NOD.Cg-PrkdcSCID/J (SCID) mice. As with C3H/HeJ mice, SCID mice inoculated with ΔrpoS/irpoS and maintained on IPTG-treated water for the entire experiment, as well as mice infected with WT Bb, were culture positive 6 and 8 weeks after inoculation (Table 2). Two weeks after discontinuation of IPTG treatment, ΔrpoS/irpoS spirochetes were recovered from 9 of 30 tissue sites cultured. 4 weeks after removal of IPTG, only 3 of 30 sites from ΔrpoS/irpoS-infected mice were culture positive. Collectively, these data demonstrate that the requirement for RpoS extends beyond early infection and that RpoS-dependent factors functionally unrelated to adaptive immunity are also required to sustain infection.
BosR is essential for transcriptional as well as repressive functions of RpoS
In addition to serving as an activator for RpoN-dependent transcription of rpoS, BosR also has been proposed as a repressor for ospA and other tick-phase genes (59, 60). The latter studies, however, were conducted in vitro and failed to divorce the requirement of BosR for RpoN-dependent transcription of rpoS from its putative repressor function. We reasoned that our IPTG-inducible irpoS allele, which dissociates transcription of rpoS from the Rrp2/BosR/RpoN complex, could be used to clarify the contribution of BosR to RpoS-mediated repression. Accordingly, we inactivated bosR in ΔrpoS/irpoS, generating the strain ΔbosRΔrpoS/irpoS. During in vitro cultivation without IPTG, ΔbosRΔrpoS/irpoS expressed neither RpoS nor OspC, whereas both were expressed in a dose-dependent manner when IPTG was added to the culture medium (Supplemental Figure 2C). Surprisingly, deletion of bosR ameliorated RpoS toxicity at IPTG concentrations above 50 μM (Supplemental Figure 2D). Although ΔbosRΔrpoS/irpoS Bb cultivated in DMCs in IPTG-treated rats expressed WT levels of RpoS, we observed noticeably lower levels of OspC, DbpA, BBK32, and VlsE along with incomplete repression of OspA and GlpD; this protein profile was strikingly similar to that of DMC-cultivated cDGC (Figure 4A). Complementation of ΔbosRΔrpoS/irpoS was technically challenging due to the paucity of antibiotic-resistance markers available for selection in Bb. As an alternative, we generated a bosR/irpoS strain that retained the native rpoS gene. Like ΔbosRΔrpoS/irpoS, ΔbosR/irpoS grew normally in vitro in the presence of over 50 μM IPTG (Supplemental Figure 2E) and showed dysregulation of RNAP-RpoS function when cultivated in DMCs in IPTG-treated rats (Figure 4B). Complementation of bosR in the ΔbosR/irpoS background (bosRcomp) restored RpoS-mediated toxicity during in vitro cultivation with more than 50 μM IPTG (Supplemental Figure 2F) as well as RpoS-dependent facets of mammalian host-adaption in rats given IPTG (Figure 4B). Moreover, unlike ΔrpoS/irpoS, ΔbosRΔrpoS/irpoS was avirulent in C3H/HeJ and SCID mice treated with IPTG (Table 3), demonstrating that murine infectivity requires BosR as well as RpoS.
BosR works cooperatively with RpoS to promote virulence in mice by an RpoN-independent mechanism
We next performed RNA-Seq on DMC-cultivated ΔbosRΔrpoS/irpoS Bb with and without IPTG to determine the RpoN-independent contribution of BosR to shaping the RpoS regulon in mammals (Supplemental Table 3). Of the 92 RpoS-upregulated genes in DMCs — 52 core and 40 DMC-only — 53 required BosR for transcription, as they were not upregulated in the ΔbosRΔrpoS/irpoS strain under inducing conditions (Supplemental Table 5 and 7). Moreover, all but 2 of the remaining 39 RpoS-upregulated genes showed lower folds of regulation in the absence of BosR. For example, transcripts for ospC increased by only 14-fold following induction of RpoS in ΔbosRΔrpoS/irpoS compared with 984-fold in WT compared with ΔrpoS (Supplemental Tables 3 and 5). Indeed, the immunoblots for OspC, DbpA,and BBK32 revealed that these transcriptional differences appear to be biologically relevant at the protein level (Figure 4A). Most strikingly, 75 of 77 RpoS-repressed genes were not downregulated in ΔbosRΔrpoS/irpoS despite induction of RpoS (Supplemental Table 8). The above results indicated that RNAP-RpoS function in mammals is highly dependent on BosR. This conclusion was supported by PCA and hierarchical clustering analyses (Figure 3), which suggest similarity between the transcriptomes of ΔrpoS and ΔbosRΔrpoS/irpoS in IPTG-treated rats. In contrast, the effect of ligand-bound PlzA on RpoS-dependent gene regulation was selective, affecting only 55 of 75 BosR/RpoS-repressed genes (Supplemental Table 8) and 16 of 90 BosR/RpoS-upregulated genes in DMCs (Supplemental Tables 5 and 7).
The ability of microorganisms to adapt rapidly and reversibly to endogenous and exogenous signals is essential for survival in dynamic, often hostile, environments. Consequently, most bacteria have evolved a general stress response to defend against initiating threats as well as seemingly unrelated stresses (61, 62). In E. coli and other γ-proteobacteria these broad adaptive responses are coordinated by the alternative σ factor σs/RpoS (61, 62). The strict dual host lifestyle of Bb, on the other hand, presents LD spirochetes with predictable exogenous and endogenous signals that have enabled them to develop programmatic transcriptional responses for each phase of the enzootic cycle (7, 16). The requirement for c-di-GMP, acting primarily through PlzA, during tick feeding has established the importance of this second messenger for vector adaptation (7, 16). Bb also has appropriated an RpoS distantly related to its Gram-negative prototype to regulate a parallel adaptive response required for migration out of the nymphal midgut, but that, unlike c-di-GMP signaling, continues following transmission (7, 11). TBDCapSeq revealed that the RpoS-ON state during transmission and mammalian infection produces distinct transcriptional profiles based on the presence or absence of c-di-GMP, respectively. These results mirror recent findings demonstrating that the c-di-GMP effector PlzA toggles between tick- and mammalian-phase conformations based on c-di-GMP binding (11, 63). Functional overlap between these evolutionarily related σ factors RpoS and RpoD is well-recognized in other bacteria (64–67). Herein we show that BosR and ligand-bound PlzA function in a reciprocal manner to contour the RpoS regulon in ticks and mammals by modulating promoter recognition by RNAP-RpoS and RNAP-RpoD.
It is universally accepted that Bb’s Fur ortholog BosR forms a complex with RNAP-RpoN and the response regulator Rrp2 to transcribe rpoS (7) (Figure 6). Whether BosR serves additional transcriptional role(s) has been a matter of debate. Seshu, Hyde, and colleagues (68, 69) reported that BosR activates an oxidative stress response in vitro following exposure to t-butyl peroxide. By TBDCapSeq, however, we saw no differences in transcript levels for putative BosR-dependent genes (i.e., napA and sod) associated with detoxification of ROS in ticks or DMCs. We note that our study was not designed to identify putative BosR-dependent, RpoS-independent genes. Shi, et al. (60) found that when expressed at supra-physiological levels in vitro in a ΔrpoS strain, BosR binds to cis sites upstream of the ospA promoter to block transcription by RNAP-RpoD. Our current and previous studies showed clearly that RpoS-mediated repression of tick-phase genes, including ospA, is a mammalian host–phase phenomenon that does not occur in the absence of RpoS (11, 15, 70). Our experiments with a Bb strain that expresses an IPTG-inducible rpoS in a ΔbosR background resolved these ostensibly discordant findings in an unexpected manner; RNAP-RpoS was unable to downregulate tick-phase genes without BosR, implying that repression requires a collaboration between the two. Moreover, collaboration between BosR and RNAP-RpoS extends beyond repression of prototypical tick-phase genes. TBDCapSeq revealed a second group of BosR/RpoS-repressed genes, exemplified by bbd18, that are transcribed exclusively by RNAP-RpoD in feeding nymphs and DMCs (Supplemental Table 2). In the absence of RpoS, however, transcript levels for these genes are significantly increased only in mammals. We interpret these data to mean that the promoters for these genes are recognized by RNAP-RpoD more efficiently in mammals and that RpoS-mediated repression is required to ensure basal levels of expression during infection. Negative regulation by competing σ factors (i.e., promoter occlusion) is well-recognized in other bacteria, including E. coli (71, 72). In the case of bbd18, derepression following acquisition by a naive vector, when RpoN-dependent transcription of rpoS is off, likely enhances degradation of residual RpoS to facilitate midgut colonization (41). Remarkably, BosR also was required for optimal expression of many RpoS-upregulated genes in DMCs, indicating that it functions as a transcriptional activator for RpoS as well as for RpoN.
Proposed model for the reciprocal regulation of the RpoS gatekeeper by BosR and ligand-bound PlzA. Top: Transcription of rpoS by RNAP complexed with BosR/Rrp2/RpoN in feeding nymphs and mammals is unaffected by either c-di-GMP (yellow circle) or PlzA. Left: In mammals, BosR enhances transcription of RpoS-upregulated core and DMC-only genes and is required for RpoS-mediated repression of tick-phase genes. RNAP-RpoS/BosR complex binds upstream of RpoS-repressed tick-phase genes, including ospA and the glp operon, preventing transcription by RNAP-RpoD. Due to the absence of c-di-GMP within mammals, apo PlzA is unable to interact with RNAP and/or prevent BosR’s σ activator function. Right: In feeding nymphs, ligand-bound PlzA interferes with BosR function, reducing expression of some RpoS-upregulated genes, including ospC, dbpA, and vlsE, and antagonizing RpoS-mediated repression either by blocking BosR binding to RNAP-RpoS or allosteric interactions with RNAP-RpoS/BosR. Based on this model, BosR’s σ activator function is specific to RNAP-RpoS, while ligand-bound PlzA interacts with both RNAP-RpoS and RNAP-RpoD in feeding nymphs. Ligand-bound PlzA also is required for RpoD-dependent transcription of glp genes, while tick-phase genes with strong promoters, such as ospA, are transcribed by RNAP-RpoD alone.
Canonical Furs repress transcription by metal-dependent binding to DNA at one or more conserved palindromic sites, or fur boxes, thereby blocking promoter recognition by RNAP-RpoD (73, 74). Ouyang, et al. (75) previously identified BosR boxes upstream of rpoS. However, only a handful of RpoS-regulated genes identified by TBDCapSeq contain putative BosR boxes within their upstream regions (75); thus, it seems unlikely that DNA binding by BosR is a prerequisite for all of its modulatory functions. In other bacteria, factors designated σ activators regulate promoter recognition by RNAPs, including RNAP-RpoS, without binding to specific DNA sequences (76, 77). In E. coli, the RpoS-specific σ activator Crl facilitates and stabilizes holoenzyme assembly by tethering RpoS to RNAP via the β′ subunit clamp toe domain (76, 78, 79). Although structurally unrelated to Crl, BosR could be acting analogously by recruiting RNAP to RpoS-dependent promoters. BosR is predicted to have noncanonical structural features that potentially explain its postulated ability to interact with DNA and RNAP-RpoS (Supplemental Figure 4). It contains an elongated, C-terminal intrinsically disordered region (IDR) reminiscent of another RpoS-specific σ activator, Pseudomonas aeruginosa SutA, whose C-terminal IDR stabilizes its interaction with RNAP (80, 81). Although BosR contains a highly conserved structural metal-binding site (i.e., CxxC motif,), which is required for dimerization, it lacks a recognizable regulatory metal binding site (7). BosR also contains an additional α-helix within its N-terminal DNA-binding domain (82, 83). Previously, we mapped the RpoS repression site for ospA to within 47 nucleotides upstream of the transcriptional start site (70). Conceivably, DNA binding by BosR is particularly important for anchoring RNAP-RpoS holoenzyme at or near the promoters for tick-phase genes, blocking recognition by RNAP-RpoD. Along these same lines, the BosR-dependent toxicity associated with overexpression of RpoS in vitro likely reflects overexpression of RpoS-upregulated genes and/or reduced expression of one or more essential gene products due to competition with RNAP-RpoD (84).
The mechanism by which ligand-bound PlzA serves as the effector for c-di-GMP-dependent survival in ticks remains unclear. Klebsiella pneumoniae MrkH, a c-di-GMP-dependent transcriptional activator and PlzA ortholog (25, 85), provides a structural framework for deconvoluting PlzA’s global regulatory functions. Binding of c-di-GMP by MrkH induces conformational changes that enable it to bind to DNA and the C-terminal domain of RNAP α subunit (α-CTD) (85). As with MrkH, c-di-GMP binding by PlzA brings together its N-terminal PilZN3 and C-terminal PilZ β-barrels and likely positions 3 positively charged helices within the PilZN3 domain to create a potential interface for DNA binding (25, 63, 86). Based on an analysis of PlzA-dependent expression of glpF, the prototypical c-di-GMP-regulated, tick-phase gene, Zhang et al. (87) proposed that PlzA interacts directly with RNAP-RpoD. Our prior and current results are in accord with this supposition (10, 25). Tan et al. (85) identified 5 surface-exposed residues on the α-CTD required for MrkH-dependent transcription of the mrkHI operon; all 5 residues (L271, R276, N279, C280, and E284) are conserved in Bb α-CTD. Unlike MrkH, PlzA also modulates RNAP-RpoS function, an activity, which, to our knowledge, has not been described for other c-di-GMP-dependent transactivators. The reciprocal effects of ligand-bound PlzA and BosR, observed for cDGC and ΔbosRΔrpoS/irpoS, at the transcriptional and protein levels, is compelling evidence that ligand-bound PlzA exerts its brake effect on RNAP-RpoS via BosR. This supposition leads to 2 possible scenarios (Figure 6). One is that ligand-bound PlzA prevents BosR from interacting with RNAP-RpoS or displaces RpoS from the RNAP holoenzyme complex. The other is that BosR remains bound to RNAP-RpoS, but ligand-bound PlzA negates BosR’s transactivator effect on RNAP-RpoS. Regardless of the mechanism, ligand-bound PlzA must be viewed as a major driving force for shaping the RpoS regulon during transmission, preventing repression of tick-phase genes and fine-tuning RpoS-dependent upregulation. In parallel, release of RpoS-mediated repression enables ligand-bound PlzA to positively regulate expression of a subset of tick-phase genes, such as glps (10, 88), while transcription of other tick-phase genes, such as ospA, by RNAP-RpoD, is PlzA-independent (10, 25). That transcription of rpoS by the BosR/Rrp2/RpoN complex is unaffected by ligand-bound PlzA (Figure 6) underscores the specificity of these postulated PlzA-BosR interactions for RNAP-RpoS complexed with both BosR and RpoS. As important as ligand-bound PlzA is for modulating the RpoS regulon during transmission, the wide divergence between cDGC in DMCs and WT Bb in feeding nymphs points to substantial input from RpoS-independent regulatory factors, including the 3 (SpoVG, BpuR, and CarD) identified by TBDCapSeq, in shaping the global Bb transcriptome in ticks.
During transmission, the RpoS-ON state is transient, remaining active in ticks only during feeding (approximately 96 hours after attachment) or perhaps shortly thereafter during the postrepletion period. Not so, however, in mammals. After establishing themselves at the site of inoculation, LD spirochetes must not only disseminate but also persist at metastatic cutaneous sites within a reservoir-competent host long enough to be acquired by a naive ixodid vector. Previously, Ouyang et al. (12) showed that rpoS transcripts could be detected in chronically infected mice but did not examine whether survival of spirochetes during chronic infection depends upon continuance of RpoS-dependent gene regulation. Use of an IPTG-inducible rpoS allele (irpoS) confirmed that RpoS is absolutely required for persistence in mice. Moreover, the appearance of OspA antibodies is compelling evidence that continued expression of RpoS also sustains the repression of tick-phase genes. Clearance of ΔrpoS/irpoS spirochetes, however, was not immediate. The mammalian host–phase regulon provides multiple, mutually nonexclusive explanations for the delayed killing of organisms deprived of RpoS. Spirochetes unable to downregulate OspA cannot survive in mice (89). One, therefore, is that derepression of tick-phase lipoproteins elicits a protective antibody response. Spirochetes lacking the vls locus or unable to undergo recombinatorial switching are markedly attenuated in immunocompetent mice (30). Only recently has it become apparent that transcription of vlsE, the expression site for variable Vls lipoproteins, is RpoS-dependent (11). Parenthetically, since expression of vlsE requires the YebC transcription factor (55), this result implies that YebC collaborates with RNAP-RpoS. Loss of BBK32 would render spirochetes sensitive to antibody-mediated killing by the classical complement pathway, compounding the effects of antibody production to dysregulated tick-phase proteins and loss of VlsE defenses (32, 33). Infectivity data for ΔrpoS/irpoS in SCID mice argue that factors unrelated to adaptive immunity also contribute to clearance. The RpoS DMC regulon encodes multiple gene products involved in nutrient acquisition (e.g., OppA5), evasion of complement-mediated killing (e.g., OspEs), and chemotaxis (11, 90–93).
Comprehensive understanding of how RpoS sustains persistence will require interrogation of individual RpoS-regulated gene products throughout the mammalian host phase. Once acquired by a naive tick, rapid reversion to the RpoS-OFF state (11–13) enables unconstrained expression of tick-phase genes. While we now possess considerable insights into the mechanisms that regulate the contours of the RpoS regulon, we have none into the underlying phenomenon of how Bb distinguishes between the acquisition and transmission blood meals to determine whether RpoS should be on or off.
Cultivation of bacterial strains. Bacterial strains and plasmids used in these studies are described in Supplemental Tables 10 and 12, respectively. Details regarding routine cultivation of E. coli and Bb in vitro and in DMCs are provided in Supplemental Methods.
Routine DNA manipulation and cloning. Oligonucleotide primers used in these studies (Supplemental Table 11) were purchased from Sigma-Aldrich. Routine cloning was performed by In-Fusion HD Cloning (TaKaRa Bio Inc.). Routine and high-fidelity PCR amplifications were performed using RedTaq (Denville Scientific) and CloneAmp HiFi (TaKaRa Bio Inc.), respectively. Bb strains were transformed by electroporation (94). Details regarding generation of Bb strains expressing an IPTG-inducible rpoS allele and IPTG-induction are described in Supplemental Methods.
Murine and tick infection studies. Female C3H/HeJ or NOD.Cg-PrkdSCID/J (SCID) mice (The Jackson Laboratory) were inoculated with 1 × 105 organisms via intradermal injection. 4-to-8 weeks after inoculation, animals were sacrificed, and blood and tissues were collected for serology and culturing, respectively. Pathogen-free Ixodes scapularis larvae were purchased from Oklahoma State University Tick Rearing Facility (Stillwater, Oklahoma, USA). Naive larvae were infected by immersion (95), fed to repletion on naive C3H/HeJ mice, and allowed to molt. Infected nymphs were fed on naive C3H/HeJ mice until fully engorged as previously described (13, 96).
SDS-PAGE and immunoblotting. Details regarding routine SDS-PAGE and immunoblotting of Bb are provided in Supplemental Methods. Polyclonal antisera against FlaB (97), OspC (11), DbpA (98), GlpD (99), RpoS (100), and OspA (11) were previously described. Antisera against BBK32 C1/C1r domain (33) and VlsE C6 peptide (101) were generated by immunizing Sprague-Dawley rats (Envigo RMS Inc.) with the corresponding purified, recombinant His-tagged protein, as previously described (102).
RNA-Seq. Detailed methods for TBDCapSeq and conventional RNA-Seq are provided in Supplemental Methods. A schematic overview of TBDCapSeq is presented in Figure 1. Total RNA was isolated from engorged nymphs or DMCs, as previously described (11), converted to cDNA using SuperScript IV (Thermo Fisher Scientific), treated with RNase H, followed by second-strand synthesis with Klenow fragment (New England Biolabs). Libraries were prepared with the KAPA Hyperplus kit (Roche) using 25–50 ng of input material, according to manufacturer’s instructions. Amplified libraries were quantified, equalized, and pooled. A total of 1 μg of library pool was mixed with 5 μg of COT human DNA (Thermo Fisher Scientific) and 2 nmol of blocking oligo pool (Roche) and then dehydrated. To enrich for Bb-specific transcripts, the dried pool was resuspended in 7.5 μL Hybridization Buffer and 3 μL Hybridization Component A (Roche) and heated at 95°C for 5 minutes before the addition of 4.5 μL of custom biotinylated TBD SeqCap EZ Probes (26, 27). The mixture was heated at 95°C for 5 min and incubated at 47°C for 16–20 h. After incubation, the probes were pulled down using magnetic streptavidin SeqCap Capture beads (Roche) and washed with buffers of decreasing stringency (SeqCap EZ Hybridization and Wash Kit; Roche). The Bb-enriched material was then amplified for 16 cycles using Illumina universal primers with KAPA HiFi HotStart Ready Mix (Roche), quantified on a TapeStation 4200 (Agilent Technologies), and sequenced on a NextSeq2000 (Illumina) that generated 150 nucleotide single-end reads. Raw read data for conventional and TBDCapSeq were processed, mapped, and analyzed as described in Supplemental Methods. Raw data have been deposited in the NCBI Sequence Read Archive (SRA) database (PRJNA881286; Supplemental Table 1).
Statistics. Pairwise quantitative reverse-transcriptase PCR comparisons were evaluated by unpaired 2-tailed Student’s t tests with a 95% confidence interval using Prism v8.4.3 (GraphPad). A P value of less than 0.05 was considered statistically significant. Differential gene expression was calculated for RNA-Seq data sets using DESeq2 (103). Genes that differed by at least 3-fold with a FDR-adjusted P value (q value) of 0.05 or under were considered differentially expressed.
Study approval. All experiments involving animals were approved by the UConn Health IACUC.
MJC, AAG, AMG, JDR, and RT conceptualized the project. MJC, AAG, CG, AMG, MAM, and RT performed experiments. MJC, AAG, and JDR performed the analyses. MJC, AAG, AMG, GO, and RT developed the methodology. MJC, AAG, and JDR supervised the project. MJC, AAG, and JDR wrote the original draft of the manuscript. MJC, AAG, AMG, JDR, and RT reviewed and edited the manuscript.
The authors thank Brandon Garcia (East Carolina University, Greenville, North Carolina, USA) for providing recombinant BBK32-His for immunization. We also thank Bo Reese (UConn Center for Genome Innovation, Storrs, Connecticut, USA), and Komal Jain, Alper Gokden, and Santiago Sanchez-Vicente (Columbia University, New York, New York, USA) for their technical assistance and expertise with RNA-Seq.This work was supported by the National Institutes of Health/National Institute for Allergy and Infectious Diseases (R01AI029735 and R21AI39940 to MJC and JDR; R21AI126146 to MJC), the Global Lyme Alliance (AMG), and NIAID Intramural Research Program (AMG). RT was supported in part by the Steven & Alexandra Cohen foundation MJC and JDR are supported in part by Connecticut Children’s Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Address correspondence to: Justin D. Radolf or Melissa J. Caimano, 263 Farmington Avenue, Farmington, Connecticut 06030-3715, USA. Phone: 860.679.8480; Email: jradolf@uchc.edu (JDR); Phone: 860.679.7312; Email: mcaima@uchc.edu (MJC). AMG’s present address is: Laboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Conflict of interest: The authors have declared that no conflict of interest exists.
Copyright: © 2023, Grassmann et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Reference information: J Clin Invest. 2023;133(5):e166710.https://doi.org/10.1172/JCI166710.